000			01555 a2200385 4500
005			20250515060513.0
264		0	_c20070321
008			200703s 0 0 eng d
022			_a1527-7755
024	7		_a10.1200/JCO.2006.06.3602 _2doi
040			_aNLM _beng _cNLM
100	1		_aChow, Laura Q M
245	0	0	_aSunitinib: from rational design to clinical efficacy. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMar 2007
300			_a884-96 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Design
650	0	4	_aGastrointestinal Stromal Tumors _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIndoles _xadverse effects
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aPyrroles _xadverse effects
650	0	4	_aSunitinib
700	1		_aEckhardt, S Gail
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 25 _gno. 7 _gp. 884-96
856	4	0	_uhttps://doi.org/10.1200/JCO.2006.06.3602 _zAvailable from publisher's website
999			_c16885150 _d16885150